Plant coumestans: recent advances and future perspectives in cancer therapy
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
25019627
DOI
10.2174/1871520614666140713172949
PII: ACAMC-EPUB-61376
Knihovny.cz E-zdroje
- MeSH
- antikarcinogenní látky chemie metabolismus terapeutické užití MeSH
- fytoestrogeny metabolismus MeSH
- fytogenní protinádorové látky chemie metabolismus terapeutické užití MeSH
- kumariny chemie metabolismus terapeutické užití MeSH
- lidé MeSH
- nádory farmakoterapie prevence a kontrola MeSH
- rostliny chemie metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- antikarcinogenní látky MeSH
- coumestan MeSH Prohlížeč
- fytoestrogeny MeSH
- fytogenní protinádorové látky MeSH
- kumariny MeSH
Natural products are often used in drug development due to their ability to form unique and diverse chemical structures. Coumestans are polycyclic aromatic plant secondary metabolites containing a coumestan moiety, which consists of a benzoxole fused to a chromen-2-one to form 1-Benzoxolo[3,2-c]chromen-6-one. These natural compounds are known for large number of biological activities. Many of their biological effects can be attributed to their action as phytoestrogens and polyphenols. In the last decade, anticancer effects of these compounds have been described in vitro but there is only limited number of studies based on models in vivo. More information concerning their in vivo bioavailability, stability, metabolism, toxicity, estrogenicity, cellular targets and drug interactions is therefore needed to proceed further to clinical studies. This review focuses on coumestans exhibiting anticancer properties and summarizes mechanisms of their toxicity to cancer cells. Moreover, the possible role of coumestans in cancer prevention is discussed.
Citace poskytuje Crossref.org
Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells